Earnings Recaps

Browse reported earnings of the most popular stocks

Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025 Sep 2, 2025 Sep 1, 2025 Aug 28, 2025 Aug 26, 2025 Aug 25, 2025 Aug 22, 2025 Aug 21, 2025 Aug 20, 2025 Aug 19, 2025 Aug 18, 2025 Aug 15, 2025 Aug 14, 2025 Aug 13, 2025 Aug 12, 2025 Aug 11, 2025 Aug 9, 2025 Aug 8, 2025 Aug 2, 2025 Aug 1, 2025 Jul 30, 2025 Jul 29, 2025 Jul 25, 2025
10 companies Today

AECOM

ACM Q1 2026
Reported: 2026-02-10

AECOM's first quarter of 2026 surpassed expectations, achieving record net service revenue, adjusted EBITDA, and backlog growth despite external challenges, including a U.S. federal government shutdown.

Key takeaways
  • Net service revenue grew 5% year-over-year, adjusted for fewer billable days.
  • Backlog increased 9% to a record high, bolstered by a 1.5 book-to-burn ratio.
  • Adjusted EBITDA reached $287 million, with adjusted EPS at $1.29, both exceeding guidance.
  • The company announced a $1 billion increase in share repurchase authorization, reflecting strong cash flow and commitment to shareholder value.
  • Strategic wins include partnerships for the 2032 Olympic and Paralympic Games and Scottish Water's capital investment program, showcasing AECOM’s competitive advantages in large infrastructure projects.

Amentum Holdings, Inc.

AMTM Q1 2026
Reported: 2026-02-10

Amentum delivered a solid Q1 FY2026 performance, with revenue reaching $3.2 billion and adjusted EBITDA of $263 million, demonstrating resilience despite external challenges. The company's strategic focus on nuclear energy, space, and digital infrastructure continues to drive robust bookings and backlog growth.

Key takeaways
  • Revenue grew by 3% year-over-year, with adjusted diluted EPS increasing 6% to $0.54.
  • Net bookings totaled $3.3 billion, maintaining a book-to-bill ratio of 1.1x over the last 12 months, contributing to a $47 billion backlog, up 4%.
  • Significant contract wins include a $730 million agreement with EDF Nuclear Power and a $207 million contract in the Netherlands for energy development.
  • Strong demand signals were noted in the nuclear energy sector, with nearly $1 billion awarded in Q1, highlighting Amentum's strategic positioning.
  • The company is advancing in digital and unmanned sustainment solutions, securing important contracts and enhancing its service portfolio.

Aramark

ARMK Q1 2026
Reported: 2026-02-10

Aramark delivered robust first quarter results for fiscal 2026, with organic revenue growth of 5% to $4.8 billion, strengthened by exceptional client retention and significant new business wins.

Key takeaways
  • FSS US organic revenue grew to $3.4 billion (2%), with anticipated recovery from calendar shifts expected in Q2.
  • International sales surged over 13% year-over-year, marking the nineteenth consecutive quarter of double-digit growth.
  • Key contract wins include the largest healthcare contract in US history with Penn Medicine and a major agreement with RWJBarnabas Health in New Jersey.
  • The company is well-positioned to achieve a net new business growth target of 4% to 5% for fiscal 2026, bolstered by high retention rates and accelerated onboarding of new accounts.
  • Strong performance in the global supply chain indicates effective cost management and client service optimization amid ongoing inflationary trends.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...